C ardiovascular disease (CVD) is the leading cause of death among both men and women in the United States (U.S.). 1 Quality of CVD preventive care is suboptimal in the U.S., particularly among women, contributing to documented gender disparities in CVD outcomes. [2] [3] [4] [5] [6] [7] [8] Numerous expert guidelines have been developed to assist physicians in determining appropriate CVD preventive care based on an individual's risk level. [9] [10] [11] Utilization of these guidelines in practice is essential to reduce the burden of CVD; yet, little is known about barriers to widespread adoption of guidelines.
Delivering high-quality care is important for all health care providers. Physicians in specific subgroups, such as younger physicians and those in solo practices, may be at heightened risk of delivering less optimal care because of lack of experience and support. A recent systematic review that included studies of self-reported knowledge, attitudes, and observed medical practice (i.e., chart audits and administrative data review) assessed length of time in clinical practice as a physician characteristic that may explain variations in quality of care. 12 The review suggested that older physicians were at risk of providing lower-quality health care than their younger counterparts. 12 However, the association between physician/ practice characteristics and quality of CVD preventive care was not specifically evaluated. Therefore, it is unknown whether physician/practice characteristics predict physician awareness/incorporation, effectiveness, perceived barriers, and clinical judgment/practice regarding CVD preventive care. The purpose of this study was to determine whether there is an association between physician/practice characteristics and quality of CVD preventive care among a random sample of U.S. physicians using a cross-sectional survey and an experimental case-study design. For purposes of this study, quality of CVD preventive care was defined by several parameters including: (1) awareness and incorporation of CVD prevention guidelines, (2) self-reported effectiveness in helping patients prevent CVD, and (3) accuracy of calculation of CVD risk and consistency of preventive recommendations with national guidelines based on experimental case studies. A secondary objective was to evaluate barriers to CVD guideline adherence by physician/practice characteristics.
METHODS

Subjects
The methods of physician selection and survey design have been published previously. 13 Briefly, in November 2004, an online cross-sectional survey was administered to a stratified random sample of 500 full-time, U.S. physicians (300 primary care physicians [PCPs] , 100 obstetricians/gynecologists [OBGyns], and 100 cardiologists [CARDs]) drawn from the J. Reckner Associates national database of over 300,000 representative health care professionals. The research panel participants have been compiled over the years by multiple mechanisms (e.g., random dialing, purchased samples, referrals) and are unbiased with respect to an artificially high concentration of internet users. Regional samples for large population specialties were drawn using a ''rolling over blocks'' method to ensure that there is no overuse of samples within specialty. The initial response rate was 13%, 10%, and 15% among PCPs, OBGyns, and CARDs respectively, typical of a single mailing response rate for an epidemiologic survey. Rather than repeated mailings to individual physicians, invitations were sent to additional physicians in the database until the prespecified stratified sample sizes were achieved.
To qualify for the research study, physicians had to be board certified or board eligible in their respective specialties and be in full-time clinical practice between 3 and 30 years postresidency. Each physician completed a standardized questionnaire including demographic information, practice type and setting, and characteristics of patients in their practice.
Survey Methods
The survey included standardized questions about awareness/incorporation of 3 national CVD prevention guidelines Evidence-Based Guidelines for Women). Effectiveness in helping patients prevent CVD and perceived barriers to CVD prevention were evaluated using a 4-and 10-point Likert scale of agreement, respectively. Physicians were also asked to identify optimal levels of low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, triglycerides, Hemoglobin (HbA1c), and fasting plasma glucose for males and females. In addition, physicians were given experimental case studies to test their knowledge of the NCEP ATP III Framingham risk categories based on the Framingham global risk score (high risk =10-year absolute coronary heart disease risk 420%, established CVD, or coronary heart disease risk equivalent; intermediate risk =10-year absolute coronary heart disease risk 10% to 20%; or low risk =10-year absolute risk o10%).
Each physician was presented with 10 experimental patient cases (2 low risk, 4 intermediate risk, and 4 high-risk based on the Framingham global risk score), which included experimentally varied information about the patient's age, gender, ethnicity/race, smoking status, total cholesterol level, LDL-cholesterol level, HDL-cholesterol level, triglycerides, blood pressure, treatment for hypertension, body mass index, family history of coronary heart disease, personal history of coronary heart disease, or diabetes mellitus. The physician was asked to assign a level of risk to each of the 10 cases and then to make specific CVD preventive recommendations for the case based upon their risk level. A detailed description of the 10 experimental cases has been published previously. 13 
Statistical Methods
Descriptive statistics of the physicians' and their practices are presented as proportions and means ( AE standard deviation). Agreement with statements about awareness and incorporation of CVD prevention guidelines and perceived barriers to CVD prevention was assessed by a 10-point Likert scale (top 2 points: strongly agree/agree vs others). Agreement with statements about physician effectiveness was evaluated using a 4-point Likert scale (top point: very effective vs others). A z-statistic of proportions was used to test differences in awareness, incorporation, effectiveness, and perceived barriers between physicians based upon their age and practice type. Correct identification of lipid and glucose levels was categorized according to levels recommended by prevention guidelines. 9, 10 Differences in the percent of physicians making each type of preventive therapy recommendation by age and practice type were also evaluated with a z-statistic of proportions.
Multivariable regression models were used to investigate the effect of physician age and practice type on awareness of and adherence to CVD prevention guidelines, independent of other physician characteristics including gender and specialty. Cut points for physician age (o50 years [younger] vs 501 years [older]) were based on the age distribution of the sample. All analyses were performed using SAS software (Version 9.1.3, SAS Institute Inc., Cary, NC). Statistical significance was set at Po.05.
RESULTS
Physician/Practice Characteristics
Characteristics of the physician's and their practices are provided in Table 1 . Compared with younger physicians (o50 years), older physicians (501 years) were more likely to be male (Po.001) and in solo practices (Po.001), and less likely to specialize in primary care (P =.02). Similar to previous research, 12 physician age and number of years in practice were highly correlated (r =.89, Po.001). 
Awareness/Incorporation of CVD Prevention Guidelines
Among all physicians, there was a relatively high level of awareness of NCEP ATP III (89%) and JNC 7 guidelines (86%), while awareness of the more recently published AHA Evidence-Based Guidelines for Women was lower (64%). Physician awareness of these CVD prevention guidelines differed significantly by physician age and practice type (solo vs nonsolo) after controlling for physician specialty and gender in a multivariable logistic regression model (Fig. 1) . Age was a significant, independent predictor of NCEP ATP III guideline awareness, with older physicians (501 years) reporting greater awareness than physicians o50 years (P =.04). In addition, nonsolo practitioners reported heightened awareness of NCEP ATP III guidelines versus solo practitioners (P =.04).
Despite relatively high levels of guideline awareness among physicians, Figure 2 demonstrates that self-reported incorporation of guidelines was lower than awareness levels (NCEP ATP III 50% versus JNC 7 44% versus AHA Women's 36%). Incorporation of the AHA Women's Guidelines varied by physician age; older physicians (501 years) were significantly more likely to report incorporating the AHA Women's Guidelines for the treatment and prevention of CVD in women and using them in evaluating risk and making treatment recommendations in their practice when compared with physicians o50 years in a multivariable model controlling for physician specialty, gender, and practice type (P =.02). In stratified analysis according to physician age and specialty (Fig. 3, online) , older cardiologists (501 years) were significantly more likely to report incorporating NCEP ATP III (P =.02), JNC 7 (Po.01), and AHA Women's Guidelines (P =.02) compared with younger cardiologists (o50 years).
Physician Effectiveness
Overall, physicians' self-reported effectiveness for helping patients prevent CVD was low ( 
Preventive Recommendations
Preventive recommendations made for patients, based upon experimental case studies, are listed in Table 3 according to the experimental case's risk level (as assessed by the physician) and physician age. In a multivariable model controlling for physician specialty, gender, and practice type, older physicians (501 years) were less likely than younger physicians (o50 years) to recommend weight management for high-risk cases with a body mass index =27 kg/m 2 (68% vs 76%, P =.03). Preventive recommendations made by practice type and case risk level (calculated by the physician) are presented in Table 4 . Solo practitioners were more likely to recommend aspirin therapy for low-risk female cases than nonsolo practitioners (49% vs 36%, P =.02).
Correct identification of an optimal LDL-cholesterol level varied by physician/practice characteristics. While over 50% of the sample identified an optimal LDL-cholesterol level as o100 mg/dL (2.59 mmol/L), younger physicians (o50 years) were significantly more likely to identify this goal than older physicians (501 years) in a multivariable regression model controlling for physician specialty and gender (60% vs 46%, P =.01), as were nonsolo practitioners versus solo practitioners (58% vs 45%, P =.02).
Physician Barriers to CVD Prevention
Barriers to CVD prevention rated by the respondents are presented in Table 5 (online) by physician age and practice type. A greater percentage of older physicians (501 years) reported that they are more likely to adopt treatment guidelines into practice that are published within their own specialty versus physicians o50 years (26% vs 18%, P =.03), as did solo practitioners versus nonsolo practitioners (28% vs 19%, P =.03). w Significant difference found in a multivariable regression model when controlling for physician specialty and gender. Solo practitioners also rated their clinical judgment as more effective than guidelines in improving health outcomes for their patients versus nonsolo practitioners (14% vs 6%, P =.004), and more frequently rated the greatest barrier to CVD prevention to be the patient him/herself (39% vs 24%, P =.003).
DISCUSSION
A main finding in our study was that while older physicians (501 years) reported a higher level of awareness and incorporation of national CVD prevention guidelines than younger physicians, they demonstrated equal or poorer adherence to national CVD prevention guidelines as their younger counterparts based upon their responses to experimental case studies. The discrepancy between self-reported awareness/ incorporation and case-study performance may be attributed to self-report bias or deficits in the application of CVD prevention guidelines. Our data are concordant with a systematic review of studies published between 1966 and 2004, which provided empirical results about medical knowledge and quality-of-care outcomes using years in clinical practice (or physician age) as an explanatory variable. 12 The review found that increasing physician age independently influenced knowledge and quality of care. In particular, it was found that physicians who were in practice longer were at risk for providing lower-quality care. Our study also found physician/practice characteristics to be significant predictors of preventive recommendations and selfreported effectiveness. Specifically, increased age and solo practice type were correlated with nonadherence to aspirin therapy and weight-management recommendations and reduced self-reported effectiveness in counseling patients on weight management. Our data found that older physicians were less likely to recommended weight management when appropriate. 9 The documented undertreatment of overweight/obesity by physicians may be, in part, because of the relatively poor efficacy of current treatments for obesity. 14, 15 However, even minor, short-term weight loss can lead to improved cardiovascular health, suggesting that continuing medical education and support on weight-management recommendations should be targeted to older physicians, especially in light of the growing obesity epidemic identified in the U.S. and the association between obesity and CVD. 1, 16 Additionally, we found that, overall, physicians felt ineffective in helping patients maintain a healthy weight, consistent with previous research. Tsui et al. 17 showed that few physicians' feel very effective in weight-management counseling. Our data extend this finding to show that older physicians feel even less effective than younger physicians, a potential result of a physician's professional and personal experience with weight/waist expansion in middle to older age. Our study found that older physicians and solo practitioners were less likely to correctly identify an LDL-cholesterol level o100 mg/dL (2.59 mmol/L) as optimal despite NCEP ATP III and AHA guidelines consistently stating o100 mg/dL (2.59 mmol/L) is optimal for all persons and a recent update to NCEP ATP III suggesting an LDL-cholesterol level o70 mg/ dL (1.81 mmol/L) is an optional target for high-risk patients. 9, 10, 18 Both epidemiological and randomized clinical trial data support that the attainment of optimal lipid levels is associated with decreased CVD morbidity and mortality. Our data underscore the need for physician education on optimal lipid levels and established therapies to manage lipids. Our data documented that nonsolo practitioners reported a higher level of awareness of national CVD prevention guidelines and that solo practitioners were more likely to recommend aspirin therapy for low-risk female cases, which is inconsistent with national evidence-based guidelines for CVD prevention in women. 9 The routine use of aspirin among women with a 10-year absolute risk o10% is a Class III, Level B recommendation, suggesting there is no overall benefit and possible adverse effects of aspirin in low-risk women. 9 Although a recent study among low-risk women found a benefit for ischemic stroke among women over 65 years of age who were randomized to aspirin versus placebo, this study was not published at the time of our data collection. Moreover, the overall CVD impact for low-risk women was null and side effects were frequent. 19 Compared with previous research on myocardial infarction patients, we did not find differences in aspirin therapy recommendations for high-risk cases in our study, which may be because of secular trends in management as most recent research on utilization of aspirin among highrisk subjects' shows significant levels of adherence. 13, [20] [21] [22] [23] Overall, awareness of CVD prevention guidelines was found to be high in our study. However, the majority of physicians reported much lower rates of incorporation of CVD prevention guidelines into practice. A similarly low rate of guideline incorporation was found in a national survey of family physicians. 24 Solo practitioners in this study were less aware of and vested in CVD prevention guidelines, consistent with previous literature documenting that physicians in solo practices adopt significantly fewer guidelines/procedures compared with those in nonsolo practices. 25, 26 Significantly more solo practitioners strongly agreed that their clinical judgment is usually more effective than guidelines in improving health outcomes in their patients and that the greatest barrier to CVD prevention is the patient compared with nonsolo practitioners. Both older physicians and solo practitioners reported a greater willingness to adopt treatment guidelines into their practice that have been published by professionals within their own specialty, rather than outside their specialty, compared with their counterparts. This finding may explain why CVD prevention guidelines are less likely to be adopted by physicians in specialties other than those writing the guidelines and suggests a more inclusive approach to writing groups may lead to more robust acceptance of guidelines. 13 Future research should explore these and other potential barriers to guideline adoption. Efforts should be directed toward the establishment of cross-discipline partnerships to develop and disseminate CVD prevention guidelines, as this may lead to improved quality of CVD preventive care. Less than half of all physicians (47%) in this study correctly categorized a patient's risk level based upon the experimental case data provided. An equal proportion of the remaining 53% of physicians either overestimated or underestimated the patient's risk level. This finding suggests that almost half of all physicians are misclassifying their patients risk level and, thus, providing inappropriate treatment. Further education and training on appropriate utilization of CVD prevention guidelines are desperately needed to improve classification of risk and quality of CVD preventive care provided.
Our study has limitations. The results may not generalize to all physicians as our response rate was limited by design, we did not survey every specialty, and only full-time, practicing physicians participated. Also, there are inherent limitations on self-report of outcomes. Despite this, our data may represent a best-case scenario among full-time practitioners as survey respondents may be more likely to be aware of and adhere to guidelines because of selection bias. We were unable to evaluate differences in recommendations for beta blocker therapy observed in other research studies as high-risk cases in our study were already assigned treatment. We lacked the power to examine whether awareness/incorporation of and adherence to CVD prevention varied by physician gender or race/ethnicity, and no adjustments were made for multiple comparisons and statistical tests. Our results need to be validated in other cohorts and by other study designs.
In conclusion, our data suggest that targeting education and support for CVD prevention may be helpful for physicians, especially those demonstrating deficits in knowledge, risk-level calculation, or performance. Educational interventions for physician subpopulations may improve knowledge of and adherence to CVD prevention guidelines and lead to improved quality outcomes.
